Legal & General Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Sell
44,157
-13,858
-24% -$3.34M ﹤0.01% 1147
2025
Q1
$14.1M Sell
58,015
-917
-2% -$223K ﹤0.01% 957
2024
Q4
$19.4M Sell
58,932
-7,696
-12% -$2.53M 0.01% 839
2024
Q3
$22.3M Sell
66,628
-40,706
-38% -$13.6M 0.01% 806
2024
Q2
$29.3M Sell
107,334
-9,859
-8% -$2.69M 0.01% 723
2024
Q1
$40.5M Sell
117,193
-4,463
-4% -$1.54M 0.01% 662
2023
Q4
$39.3M Sell
121,656
-8,728
-7% -$2.82M 0.01% 673
2023
Q3
$46.7M Sell
130,384
-7,113
-5% -$2.55M 0.02% 644
2023
Q2
$52.1M Buy
137,497
+3,348
+2% +$1.27M 0.02% 628
2023
Q1
$64.3M Sell
134,149
-1,354
-1% -$649K 0.02% 575
2022
Q4
$57M Sell
135,503
-8,985
-6% -$3.78M 0.02% 588
2022
Q3
$60.3M Sell
144,488
-3,686
-2% -$1.54M 0.02% 585
2022
Q2
$73.3M Sell
148,174
-11,488
-7% -$5.69M 0.03% 567
2022
Q1
$89.9M Buy
159,662
+3,243
+2% +$1.83M 0.03% 557
2021
Q4
$118M Sell
156,419
-7,015
-4% -$5.3M 0.04% 486
2021
Q3
$122M Sell
163,434
-5,556
-3% -$4.14M 0.04% 475
2021
Q2
$109M Buy
168,990
+7,752
+5% +$4.99M 0.04% 513
2021
Q1
$92.1M Buy
161,238
+4,382
+3% +$2.5M 0.03% 532
2020
Q4
$91.4M Buy
156,856
+1,245
+0.8% +$726K 0.04% 506
2020
Q3
$80.2M Buy
155,611
+51,627
+50% +$26.6M 0.04% 478
2020
Q2
$46.9M Sell
103,984
-8,973
-8% -$4.05M 0.02% 581
2020
Q1
$39.6M Buy
112,957
+3,754
+3% +$1.32M 0.02% 574
2019
Q4
$40.4M Buy
109,203
+51,311
+89% +$19M 0.02% 649
2019
Q3
$19.3M Buy
57,892
+10,137
+21% +$3.37M 0.01% 796
2019
Q2
$14.9M Buy
47,755
+17,626
+59% +$5.51M 0.01% 868
2019
Q1
$9.21M Buy
30,129
+877
+3% +$268K 0.01% 915
2018
Q4
$6.79M Buy
29,252
+1,595
+6% +$370K 0.01% 939
2018
Q3
$8.66M Buy
27,657
+188
+0.7% +$58.8K 0.01% 913
2018
Q2
$7.93M Sell
27,469
-856
-3% -$247K 0.01% 919
2018
Q1
$7.08M Buy
28,325
+1,476
+5% +$369K 0.01% 936
2017
Q4
$6.41M Buy
26,849
+1,987
+8% +$474K ﹤0.01% 952
2017
Q3
$5.53M Buy
24,862
+2,443
+11% +$543K ﹤0.01% 976
2017
Q2
$5.07M Buy
22,419
+3,107
+16% +$703K ﹤0.01% 966
2017
Q1
$3.85M Buy
19,312
+5,489
+40% +$1.09M ﹤0.01% 1081
2016
Q4
$2.52M Buy
13,823
+3,370
+32% +$614K ﹤0.01% 1243
2016
Q3
$1.71M Buy
10,453
+234
+2% +$38.3K ﹤0.01% 1143
2016
Q2
$1.46M Buy
10,219
+1,523
+18% +$218K ﹤0.01% 1062
2016
Q1
$1.19M Sell
8,696
-1,493
-15% -$204K ﹤0.01% 1074
2015
Q4
$1.41M Buy
10,189
+2,666
+35% +$370K ﹤0.01% 1040
2015
Q3
$1.01M Buy
7,523
+411
+6% +$55.2K ﹤0.01% 1113
2015
Q2
$1.07M Buy
7,112
+2,170
+44% +$327K ﹤0.01% 1129
2015
Q1
$668K Buy
4,942
+584
+13% +$78.9K ﹤0.01% 1220
2014
Q4
$525K Sell
4,358
-307
-7% -$37K ﹤0.01% 1240
2014
Q3
$529K Hold
4,665
﹤0.01% 1187
2014
Q2
$558K Hold
4,665
﹤0.01% 1146
2014
Q1
$598K Hold
4,665
﹤0.01% 1095
2013
Q4
$577K Buy
4,665
+3,079
+194% +$381K ﹤0.01% 1105
2013
Q3
$186K Buy
1,586
+472
+42% +$55.4K ﹤0.01% 1251
2013
Q2
$125K Buy
+1,114
New +$125K ﹤0.01% 1238